Study of allopregnanolone for PMDD in women on SSRIs
Treatments studied
Part of Mental health clinical trials.
This trial studies a natural brain chemical called allopregnanolone in women with premenstrual dysphoric disorder (PMDD) that responds to SSRI antidepressants. It aims to understand how the brain adapts and whether this treatment could help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female
- You are between 18 and 50 years old
- You have regular menstrual cycles (24 to 35 days)
- You speak and understand English fluently
- You have PMDD that improves with SSRI medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for chemical markers in the blood that might help diagnose PMDD. It involves blood draws and questionnaires over one or two menstrual cycles to see how your body responds to natural hormone changes.
This study tests an experimental medicine for premenstrual dysphoric disorder (PMDD), a severe form of PMS. It is a phase 1 trial, so the main goal is to check the drug's safety and how your body handles it, but it may also help assess its effectiveness.
This trial tests whether allopregnanolone, a natural brain chemical, can help depression in women going through menopause. It compares the effects against a placebo to see if it improves mood symptoms.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.
This study looks at how changes in hormone levels during the menstrual cycle affect mood and the brain's reward system in women with depression that gets worse before their period. The goal is to understand why this happens so better treatments can be developed.
Hear when a new Premenstrual Dysphoric Disorder (PMDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.